203 related articles for article (PubMed ID: 11239199)
1. Mechanisms that produce nitric oxide-mediated relaxation of cerebral arteries during atherosclerosis.
Didion SP; Heistad DD; Faraci FM
Stroke; 2001 Mar; 32(3):761-6. PubMed ID: 11239199
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of 4-aminopyridine on responses of the basilar artery to nitric oxide.
Sobey CG; Faraci FM
Br J Pharmacol; 1999 Mar; 126(6):1437-43. PubMed ID: 10217538
[TBL] [Abstract][Full Text] [Related]
3. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
[TBL] [Abstract][Full Text] [Related]
4. Contribution of 20-HETE to vasodilator actions of nitric oxide in the cerebral microcirculation.
Alonso-Galicia M; Hudetz AG; Shen H; Harder DR; Roman RJ
Stroke; 1999 Dec; 30(12):2727-34; discussion 2734. PubMed ID: 10583004
[TBL] [Abstract][Full Text] [Related]
5. Activation of protease-activated receptor-2 (PAR-2) elicits nitric oxide-dependent dilatation of the basilar artery in vivo.
Sobey CG; Cocks TM
Stroke; 1998 Jul; 29(7):1439-44. PubMed ID: 9660401
[TBL] [Abstract][Full Text] [Related]
6. Role of soluble guanylate cyclase in dilator responses of the cerebral microcirculation.
Faraci FM; Sobey CG
Brain Res; 1999 Mar; 821(2):368-73. PubMed ID: 10064823
[TBL] [Abstract][Full Text] [Related]
7. Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles.
Sobey CG; Faraci FM
Stroke; 1997 Apr; 28(4):837-42; discussion 842-3. PubMed ID: 9099205
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) of responses to nitric oxide-donors in rat pulmonary artery: influence of the mechanism of nitric oxide generation.
Homer KL; Fiore SA; Wanstall JC
J Pharm Pharmacol; 1999 Feb; 51(2):135-9. PubMed ID: 10217311
[TBL] [Abstract][Full Text] [Related]
9. The effect of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide.
Onoue H; Katusic ZS
Brain Res; 1998 Feb; 785(1):107-13. PubMed ID: 9526059
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation.
Tseng CM; Tabrizi-Fard MA; Fung HL
J Pharmacol Exp Ther; 2000 Feb; 292(2):737-42. PubMed ID: 10640313
[TBL] [Abstract][Full Text] [Related]
11. The vasorelaxation of cerebral arteries by carbon monoxide.
Komuro T; Borsody MK; Ono S; Marton LS; Weir BK; Zhang ZD; Paik E; Macdonald RL
Exp Biol Med (Maywood); 2001 Oct; 226(9):860-5. PubMed ID: 11568310
[TBL] [Abstract][Full Text] [Related]
12. Relaxation to authentic nitric oxide and SIN-1 in rat isolated mesenteric arteries: variable role for smooth muscle hyperpolarization.
Plane F; Sampson LJ; Smith JJ; Garland CJ
Br J Pharmacol; 2001 Jul; 133(5):665-72. PubMed ID: 11429390
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide and sodium nitroprusside-induced relaxation of the human umbilical artery.
Lovren F; Triggle C
Br J Pharmacol; 2000 Oct; 131(3):521-9. PubMed ID: 11015303
[TBL] [Abstract][Full Text] [Related]
14. Vasorelaxing effects of propranolol in rat aorta and mesenteric artery: a role for nitric oxide and calcium entry blockade.
Priviero FB; Teixeira CE; Toque HA; Claudino MA; Webb RC; De Nucci G; Zanesco A; Antunes E
Clin Exp Pharmacol Physiol; 2006; 33(5-6):448-55. PubMed ID: 16700877
[TBL] [Abstract][Full Text] [Related]
15. Gene transfer of inducible nitric oxide synthase impairs relaxation in human and rabbit cerebral arteries.
Gunnett CA; Lund DD; Howard MA; Chu Y; Faraci FM; Heistad DD
Stroke; 2002 Sep; 33(9):2292-6. PubMed ID: 12215601
[TBL] [Abstract][Full Text] [Related]
16. NO- activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries.
Irvine JC; Favaloro JL; Kemp-Harper BK
Hypertension; 2003 Jun; 41(6):1301-7. PubMed ID: 12743008
[TBL] [Abstract][Full Text] [Related]
17. Extracellular nitric oxide release mediates soluble guanylate cyclase-independent vasodilator action of spermine NONOate: comparison with other nitric oxide donors in isolated rat femoral arteries.
Miller MR; Okubo K; Roseberry MJ; Webb DJ; Megson IL
J Cardiovasc Pharmacol; 2004 Mar; 43(3):440-51. PubMed ID: 15076229
[TBL] [Abstract][Full Text] [Related]
18. The 2-nitrate-1,3-dibuthoxypropan, a new nitric oxide donor, induces vasorelaxation in mesenteric arteries of the rat.
França-Silva MS; Luciano MN; Ribeiro TP; Silva JS; Santos AF; França KC; Nakao LS; Athayde-Filho PF; Braga VA; Medeiros IA
Eur J Pharmacol; 2012 Sep; 690(1-3):170-5. PubMed ID: 22796675
[TBL] [Abstract][Full Text] [Related]
19. The role of cGMP hydrolysing phosphodiesterases 1 and 5 in cerebral artery dilatation.
Kruuse C; Rybalkin SD; Khurana TS; Jansen-Olesen I; Olesen J; Edvinsson L
Eur J Pharmacol; 2001 May; 420(1):55-65. PubMed ID: 11412839
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic hypoxia on soluble guanylate cyclase activity in fetal and adult ovine cerebral arteries.
Pearce WJ; Williams JM; White CR; Lincoln TM
J Appl Physiol (1985); 2009 Jul; 107(1):192-9. PubMed ID: 19407253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
